Skip to main content
. 2018 Nov 26;62(12):e01470-18. doi: 10.1128/AAC.01470-18

FIG 3.

FIG 3

Activity of four daily doses of moxifloxacin (MOX), plus a no-treatment control, against NRP-phenotype Mycobacterium tuberculosis 18b (streptomycin-starved) examined in a HFIM over 28 days.